98%
921
2 minutes
20
Inulin, a soluble dietary fiber, is widely recognized for its gut health benefits; however, its role in the progression of ulcerative colitis remains unclear. In this study, we investigated the effects of inulin supplementation on colitis induced by administering dextran sodium sulfate (DSS) to BALB/c mice. Mice were fed diets containing 10% inulin or cellulose, followed by administration of 2% DSS in drinking water. Inulin-supplemented mice exhibited a higher disease activity index and more severe epithelial damage compared to cellulose-fed controls. Similar pathological features were observed in mice administered polyethylene glycol to induce osmotic diarrhea, suggesting that increased luminal osmotic pressure may exacerbate colitis. Notably, co-administration of polycarbophil calcium with inulin ameliorated clinical symptoms and attenuated tissue damage. These findings suggest that inulin may aggravate colitis, potentially through increased luminal osmotic pressure. Therefore, managing osmotic diarrhea may represent a therapeutic strategy to mitigate colitis symptoms associated with certain dietary fibers.
Download full-text PDF |
Source |
---|---|
http://dx.doi.org/10.1093/bbb/zbaf129 | DOI Listing |
Biosci Biotechnol Biochem
September 2025
Department of Applied Life Sciences, Nihon University Graduate School of Bioresource Sciences, Kanagawa, Japan.
Inulin, a soluble dietary fiber, is widely recognized for its gut health benefits; however, its role in the progression of ulcerative colitis remains unclear. In this study, we investigated the effects of inulin supplementation on colitis induced by administering dextran sodium sulfate (DSS) to BALB/c mice. Mice were fed diets containing 10% inulin or cellulose, followed by administration of 2% DSS in drinking water.
View Article and Find Full Text PDFEndocr Oncol
January 2025
Department of Internal Medicine, Section of Endocrinology, ENETS Center of Excellence, Erasmus MC Cancer Institute, Rotterdam, The Netherlands.
Unlabelled: Congenital glucose-galactose malabsorption (CGGM) is a rare autosomal recessive disorder caused by a biallelic mutation of solute carrier family 5 member 1 (), encoding the sodium-dependent glucose transport-1 (SGLT-1) protein. Patients with CGGM present with neonatal-onset osmotic diarrhea due to impaired intestinal uptake of glucose. Here, we report a case of a 41-year-old female with CGGM who was referred to our clinic for symptoms of hypoglycemia, with the final diagnosis of an insulinoma, which was successfully resected.
View Article and Find Full Text PDFInflamm Bowel Dis
July 2025
Division of Gastroenterology and Hepatology, Department of Internal Medicine, Medical University of Graz, Graz, Austria.
Background: The fecal microbiome of patients with inflammatory bowel diseases (IBD) is characterized by longitudinal variability. It remains unknown if this is caused by decreased resilience of the microbiome to external factors. We investigated the influence of osmotic diarrhea induced by bowel preparation as a disruptive factor on the fecal microbiome in IBD patients and healthy comparators.
View Article and Find Full Text PDFFront Cell Infect Microbiol
December 2024
Research Institute for Farm Animal Biology (FBN), Dummerstorf, Germany.
Introduction: is the most prevalent enteric protozoan parasite causing infectious diarrhea in neonatal calves worldwide with a direct negative impact on their health and welfare. This study utilized next-generation sequencing (NGS) to deepen our understanding of intestinal epithelial barriers and transport mechanisms in the pathophysiology of infectious diarrhea in neonatal calves, which could potentially unveil novel solutions for treatment.
Methods: At day 1 of life, male Holstein-Friesian calves were either orally infected (n = 5) or not (control group, n = 5) with oocysts (in-house strain LE-01-Cp-15).
J Gastroenterol Hepatol
February 2025
Department of Gastroenterology, Beijing Friendship Hospital, Capital Medical University, Beijing, China.
Objective: The objective of this study is to compare the efficacy and safety of lubiprostone (Lub) with osmotic laxatives in the treatment of chronic idiopathic constipation (CIC).
Methods: A comprehensive literature search was conducted using PubMed, EMBASE, and the Cochrane Library in May 2024. Studies that met the inclusion criteria were manually searched by two independent reviewers.